Last reviewed · How we verify

NCT05547594

Prehabilitation in Patients With Cancer and Type 2 Diabetes

Recruiting now NA Last updated 28 May 2024
What this trial tests

NA trial testing Multimodal surgical prehabilitation in Cancer in 60 participants. Currently enrolling.

Timeline
18 January 2024
Primary endpoint
30 January 2025
30 April 2025

Quick facts

Lead sponsorUniversity of Greenwich
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment60
Start date18 January 2024
Primary completion30 January 2025
Estimated completion30 April 2025
Sites2 locations across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Greenwich

Who can join

18 and older, any sex, with Cancer or Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Surgical prehabilitation refers to pre-operative interventions aimed at increasing patients' physiological reserve so that they can better cope with the stress of surgery, avoid post-operative complications and have a faster recovery after surgery. Multimodal prehabilitation combines different aspects related to a healthy lifestyle including but not limited to; physical activity, nutritional education, anxiety coping strategies, alcohol moderation and smoking cessation. Although these aspects are well known, having a cancer diagnosis and the likelihood of an incoming operation during the weeks after diagnosis, place patients in a situation where they may be more receptive to adopting lifestyle changes aimed at promoting health. Such changes could be incorporated, not just in the short-term in preparation for surgery, but also in the medium- and long-term, improving patients' wellbeing and potentially reducing the risk of cancer reoccurrence and other diseases. Although the benefits of prehabilitation before surgery are understood, the effects it may have in non-insulin-dependent Type 2 diabetes patients are unknown. This project aims to: (i) Analyse the effects of a multimodal prehabilitation programme vs. the current National Health Service (NHS) standard approach, on physical performance in cancer patients with non-insulin-dependent Type 2 diabetes prior to surgery. (ii) Explore the impact of the programme on body composition and metabolic markers. (iii) Analyse the programme adherence, markers of well-being and quality of life during a post-surgery period of up to 12 months as well as its effects on clinical outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Perioperative Management of Patients with Diabetes and Cancer: Challenges and Opportunities.
    Shouman M, Brabant M, Rehman N, Ahmed S, et al · · 2024 · cited 3× · PMID 39199594 · DOI 10.3390/cancers16162821

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other University of Greenwich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05547594.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing